A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies

NCT04503265 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

122

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Neoplasm
Breast Cancer
Ovarian Cancer
Homologous Recombination Deficiency
Prostate Cancer
Pancreatic Cancer

Interventions

DRUG: AMXI-5001:Dose Escalation Phase I
DRUG: AMXI-5001:Dose Expansion Phase II

Sponsor

AtlasMedx, Incorporated